$0.62
+0.01 (+1.04%)
Analyst Consensus
Buy
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4,856.6% upside
Low Target
$24.11
Average Target
$30.85
High Target
$37.88
Current Price
$0.62
Current
$0.62
$0.62
Target
$30.85
$30.85
$24.11
$30.85 avg
$37.88
Scenario Analysis
Bear Case
$24.11
3,773.7%
Low target
Base Case
$30.85
+4,856.6%
Avg target
Bull Case
$37.88
+5,986.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.72
-63.8% from high
52-Week Low
$0.59
+5.8% from low
Target vs 52W High
$30.85
+1,693.6% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.02
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 35 | 86% | $369.21 | -46.9% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -31.3% |
| A | Buy | 29 | 72% | $64.69 | -63.0% |
| IQV | Strong Buy | 27 | 85% | $82.96 | -69.5% |
| WAT | Buy | 30 | 70% | $189.60 | -58.6% |
| MTD | Hold | 19 | 47% | $170.43 | -90.1% |
| ILMN | Buy | 28 | 57% | $169.36 | -20.5% |
| WST | Strong Buy | 22 | 95% | $136.24 | -65.9% |